Table 3 Pattern of prescriptions in the whole sample at t1 and t4 (n = 690)*.

From: Mental health trajectories of adolescents treated with psychotropic medications: insights from the european milestone study

 

N of patients receiving any drugs from each class among medicated patients (N = 186) (%)

N of patients receiving any drugs from each class among intermittent medicated patients (N = 304) (%)

Mean N of drugs from each class (SD) in the whole sample

N of drugs range in the whole sample

TIME POINT 1

 First-Generation Antipsychotic

8 (4.3%)

8 (2.6%)

2.0 (0.9)

1-3

 Second-Generation Antipsychotic**

59 (31.7%)

47 (15.5%)

1.8 (0.8)

1-4

 Mood Stabilizers

19 (10.2%)

7 (2.3%)

1.5 (0.7)

1-3

 Antidepressants

119 (63.9%)

109 (35.9%)

1.5 (0.7)

1-5

 Benzodiazepines

17 (9.1%)

30 (9.9%)

1.5 (0.9)

1-4

 Stimulants

60 (32.3%)

44 (14.5%)

1.3 (0.6)

1-3

 Mean N of Drugs for Each Patient (SD)

1.5 (0.8)

0.9 (0.8)

  

TIME POINT 4

 First-Generation Antipsychotic

12 (6.5%)

2 (0.7%)

1.8 (1.0)

1-3

 Second-Generation Antipsychotic**

60 (32.3%)

11 (3.6%)

1.5 (0.7)

1-3

 Mood Stabilizers

20 (10.8%)

8 (2.6%)

1.8 (0.8)

1-3

 Antidepressants

108 (58.1%)

36 (11.8%)

1.4 (0.8)

1-5

 Benzodiazepines

8 (4.3%)

16 (5.3%)

1.6 (0.7)

1-3

 Stimulants

60 (32.3%)

10 (3.3%)

1.5 (0.6)

1-3

 Mean N Of Drugs for Each Patient (SD)

1.5 (0.8)

0.4 (0.7)

  
  1. *The patients listed in specific psychotropic medication categories at baseline (T1) may not be the same patients taking the corresponding prescriptions at follow-up (T4).
  2. ** Patients receiving clozapine have been included in this row (at T1 and T4).